A

Arrowhead Pharmaceuticals

Develops RNAi-based gene-silencing therapies

Associate Medical Director / Medical Director

Biology & BiotechConfirmed live in the last 24 hours
Full-timePasadena, CA, USA$275k - $310k

About the Job

Requirements

  • An M.D. or a combined M.D./Ph.D. with research experience is required.
  • Hands-on translational research experience in a pharmaceutical or biotechnology company or an academic setting is required.
  • Demonstrated understanding of the drug development process and a strong desire to contribute to developing meaningful therapeutics are required.
  • Knowledge of Good Clinical Practices, FDA regulations and guidelines, and applicable regulatory requirements is required.
  • Ability to effectively evaluate outside expert advice is required.
  • Ability to clearly explain complex scientific and medical concepts in written and oral communication is required.
  • Ability to work independently and effectively in a fast-paced, team-based environment is required.
  • Strong clinical, scientific, and technical skills are required.
  • Strong interpersonal skills and the ability to communicate effectively with people in diverse settings are required.
  • Ability to identify challenges and problems, take initiative, and identify solutions is required.
  • Project management skills and focus on delivery of results are required.

Responsibilities

  • Support the conceptualization, design, development, execution, and communication of clinical studies across a variety of therapeutic areas.
  • Act as a medical lead in a cross-functional team that includes medical, scientific, clinical, safety, program management, and regulatory staff.
  • Communicate protocols and other relevant information effectively with clinical site investigators and staff.
  • Interpret clinical trial data and communicate results clearly and accurately.
  • Provide ongoing clinical monitoring for clinical trials, including assessing eligibility criteria, managing toxicity, and conducting drug safety surveillance.
  • Contribute to documents, including Institutional Review Board submissions, protocols, study reports, publications, and regulatory submissions, including anticipated upcoming New Drug Application/Marketing Authorisation Application submissions.
  • Provide high-level and complex scientific and clinical guidance to Clinical Trials Management, Biometrics, Global Drug Safety, Regulatory, and Project Management staff to meet project deliverables and timelines.
  • Identify key opinion leaders and participate in clinical advisory board meetings.
  • Make scientific presentations at advisory boards, key scientific meetings, and external committee meetings.
  • Identify and evaluate medical need and clinical paths for new applications of RNA interference to treat disease.
  • Monitor and understand new developments in RNA interference in industry and academia.
  • Support in-licensing and out-licensing activities and partner relationships.

Desired Qualifications

  • Fellowship training, such as cardiology or endocrinology, is preferred.
  • Research focused on lipids or obesity is preferred.

About the Company

Arrowhead Pharmaceuticals

Develops RNAi-based gene-silencing therapies

Arrowhead Pharmaceuticals develops medicines using RNA interference (RNAi) to silence disease-causing genes. The company’s approach uses a library of RNA chemistries and delivery methods to trigger RNAi, enabling rapid and durable reduction of target gene expression in cells. This gene-silencing strategy aims to treat severe genetic diseases such as cystic fibrosis and hepatitis B by lowering disease-related proteins. Arrowhead’s products are advanced through discovery and development partnerships, licensing deals, and potential commercialization of approved therapies. The company differentiates itself through a broad RNAi platform, proprietary delivery tech, and collaborations with larger pharma firms to advance its pipeline. Its goal is to provide new treatment options for conditions with limited or no effective therapies by translating gene silencing into medicines that can halt or reverse disease progression.

Company size
501-1,000
Company stage
IPO
Headquarters
Pasadena, CA
Founded
2004

Recently Posted Jobs

Explore more opportunities at Arrowhead Pharmaceuticals

See more jobs